Kazi, Aslamuzzaman <br/><br/>
Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  Jun 2009 
 - 1940-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.4161/cc.8.12.8798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--chemistry<br/>Antineoplastic Agents--chemistry<br/>Boronic Acids--chemistry<br/>Bortezomib<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Chymotrypsin--antagonists & inhibitors<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Drug Discovery<br/>Humans<br/>Inhibitory Concentration 50<br/>Intracellular Signaling Peptides and Proteins--agonists<br/>Mice<br/>Mice, Nude<br/>Neoplasms--enzymology<br/>Proteasome Inhibitors<br/>Protein Conformation<br/>Pyrazines--chemistry<br/>Serine Proteinase Inhibitors--chemistry<br/>Small Molecule Libraries<br/>Xenograft Model Antitumor Assays